Integrin as a Molecular Target for Anti-cancer Approaches in Lung Cancer

Nithikoon Aksorn1, Pithi Chanvorachote2,3

  • 1Department of Clinical Pathology, Faculty of Medicine Vajira Hospital, Navamindradhiraj University, Bangkok, Thailand.

Anticancer Research
|February 4, 2019
PubMed

Insights

Integrins are key cell adhesion molecules involved in cancer progression. Targeting specific integrins shows promise for improving lung cancer therapy and overcoming drug resistance.

Area of Science:

  • Cell Biology
  • Molecular Oncology
  • Cancer Therapeutics

Background:

  • Integrins mediate cell-matrix adhesion and signaling, crucial for cell functions.
  • These functions are implicated in cancer development and progression.
  • Specific integrins (αv, α5, β1, β3, β5) are linked to lung cancer survival and metastasis.

Purpose of the Study:

  • To review the role of integrins in lung cancer.
  • To explore integrins as potential molecular targets for anti-cancer therapies.
  • To understand how integrins contribute to drug resistance and metastasis in lung cancer.

Main Methods:

  • Literature review of studies on integrins in lung cancer.
  • Analysis of data linking integrin expression to cancer cell survival and metastasis.
  • Examination of mechanisms of integrin-mediated chemoresistance and metastatic potential.

Main Results:

  • Integrins play significant roles in lung cancer cell survival and metastasis.
  • Certain integrins enhance the metastatic potential of lung cancer cells.
  • Integrins contribute to lung cancer resistance to chemotherapeutics.

Conclusions:

  • Integrins are viable molecular targets for novel anti-cancer strategies.
  • Targeting integrins may overcome chemoresistance and reduce lung cancer metastasis.
  • Further understanding of integrin mechanisms can guide the development of new anti-cancer drugs.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.9K
Integrins01:10

Integrins

Animal and protozoan cells do not have cell walls to help maintain shape and provide structural stability. Instead, these eukaryotic cells secrete a sticky mass of carbohydrates and proteins into the spaces between adjacent cells. This network of proteins and molecules is called an extracellular matrix or ECM.
Some ECM proteins assemble into a basement membrane to which the remaining components adhere. Proteoglycans typically form the bulk of the ECM while fibrous proteins, like collagen,...
5.4K
Cancer02:18

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
54.2K
What is Cancer?02:12

What is Cancer?

Cells and tissues must meticulously coordinate their activities for the normal functioning of the human body. Therefore, they exhibit socially responsible behavior - resting, growing, dividing, differentiating, or dying - for the organism’s benefit. Cancer arises when cells divide uncontrollably and invade other tissues or organs.
Although people have known about cancer for centuries, it was only in 1761 that Giovanni Morgagni of Padua performed a detailed autopsy of...
14.4K
Activation of Integrins01:15

Activation of Integrins

Integrins bind ligands and transmit information from outside the cell to inside or vice-versa through an "outside-in signaling" or "inside-out signaling."
In "outside-in signaling," external factors in the extracellular space bind to exposed ligand binding sites on integrins. This causes the inactive protein to undergo a conformational change to become active. Integrins are often clustered on the cell membrane. Repetitive and regularly spaced ligand binding...
5.1K
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.0K